[ Price : $8.95]
FDA posts a draft guidance on antibody-drug conjugate clinical pharmacology considerations.[ Price : $8.95]
Writing in the 2/4 The Lancet, FDA Oncology Center of Excellence director Richard Pazdur calls into question the development of do...[ Price : $8.95]
A just-released Government Accountability Office report offers recommendations on an FDA-planned pilot program to test unannounced...[ Price : $8.95]
Federal Register notice: FDA extends the comment period for a 1/11 notice about a draft guidance entitled Notifying the Food and D...[ Price : $8.95]
Federal Register notice: FDA posts a draft guidance on over-the-counter monograph drug formal meetings between the agency and spon...[ Price : $8.95]
FDA issues a warning to not use the E25Bio Covid-19 Direct Antigen Rapid Test due to concerns about false results.[ Price : $8.95]
FDA removes its domestic inspection pause and will resume conducting inspections in the U.S beginning 2/7 now that Covid-19 cases ...[ Price : $8.95]
FDA issues Wells Pharma (Houston, TX) a one-item Form FDA-483 after a 6/2021 inspection at the drug outsourcing facility.